Australia markets closed

Roivant Sciences Ltd. (87S.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
9.44-0.04 (-0.42%)
At close: 03:29PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
Total revenue
124,795
124,795
61,280
55,286
23,795
Cost of revenue
15,560
15,560
13,128
8,966
2,057
Gross profit
109,235
109,235
48,152
46,320
21,738
Operating expenses
Research development
501,736
501,736
525,215
483,035
236,626
Selling general and administrative
687,443
687,443
600,506
775,033
259,878
Total operating expenses
1,189,179
1,189,179
1,125,721
1,258,068
496,504
Operating income or loss
-1,079,944
-1,079,944
-1,077,569
-1,211,748
-474,766
Interest expense
34,778
34,778
27,968
7,041
2,809
Total other income/expenses net
5,221,727
5,221,727
-151,481
294,673
-422,390
Income before tax
4,253,430
4,253,430
-1,224,834
-923,747
-898,547
Income tax expense
22,224
22,224
5,190
369
1,686
Income from continuing operations
4,231,206
4,231,206
-1,230,024
-924,116
-900,233
Net income
4,348,926
4,348,926
-1,009,030
-845,262
-809,234
Net income available to common shareholders
4,348,926
4,348,926
-1,009,030
-845,262
-809,234
Basic EPS
-1.31
5.55
-1.42
-1.26
-1.18
Diluted EPS
-1.31
5.23
-1.42
-1.26
-1.18
Basic average shares
746,234
783,249
712,791
669,753
684,789
Diluted average shares
746,234
831,049
712,791
669,753
684,789